DK0667920T3
(da)
*
|
1992-10-29 |
2003-04-14 |
Univ Jefferson |
Fremgangsmåder til påvisning af prostatacancermetastase
|
US5674682A
(en)
*
|
1992-10-29 |
1997-10-07 |
Thomas Jefferson University |
Nucleic acid primers for detecting micrometastasis of prostate cancer
|
US6103237A
(en)
*
|
1993-07-22 |
2000-08-15 |
Hybritech Incorporated |
Stable variant hK2 polypeptide
|
US5976794A
(en)
*
|
1994-04-15 |
1999-11-02 |
The Trustees Of Columbia University In The City Of New York |
Method for molecular staging of prostate cancer
|
CA2189774A1
(en)
*
|
1994-05-10 |
1995-11-16 |
Donald J. Tindall |
Recombinant hk2 polypeptide
|
US5866679A
(en)
*
|
1994-06-28 |
1999-02-02 |
Merck & Co., Inc. |
Peptides
|
US5599686A
(en)
*
|
1994-06-28 |
1997-02-04 |
Merck & Co., Inc. |
Peptides
|
US6143864A
(en)
*
|
1994-06-28 |
2000-11-07 |
Merck & Co., Inc. |
Peptides
|
AU4897896A
(en)
*
|
1995-01-04 |
1996-07-24 |
Trustees Of Boston University |
Primers for the pcr amplification of metastatic sequences
|
AUPN274295A0
(en)
*
|
1995-05-02 |
1995-05-25 |
Garvan Institute Of Medical Research |
GDU, a novel signalling protein
|
US5882864A
(en)
*
|
1995-07-31 |
1999-03-16 |
Urocor Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate disease
|
US6218529B1
(en)
|
1995-07-31 |
2001-04-17 |
Urocor, Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
|
US7785842B2
(en)
*
|
1996-03-26 |
2010-08-31 |
Oncomedx, Inc. |
Comparative analysis of extracellular RNA species
|
US6329179B1
(en)
*
|
1996-03-26 |
2001-12-11 |
Oncomedx, Inc. |
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
|
US8043835B1
(en)
|
1996-03-26 |
2011-10-25 |
Oncomedx, Inc. |
Methods for detecting and monitoring cancer using extracellular RNA
|
US6759217B2
(en)
*
|
1996-03-26 |
2004-07-06 |
Oncomedx, Inc. |
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
|
US5861248A
(en)
*
|
1996-03-29 |
1999-01-19 |
Urocor, Inc. |
Biomarkers for detection of prostate cancer
|
AU2676197A
(en)
*
|
1996-04-16 |
1997-11-07 |
Smithkline Beecham Corporation |
A method for detection of prostate specific antigen used in monitoring and diagnosis of prostate cancer
|
US5925519A
(en)
*
|
1996-06-03 |
1999-07-20 |
The Regents Of The University Of California |
Genetic alterations associated with prostate cancer
|
US6479263B1
(en)
|
1996-11-14 |
2002-11-12 |
Baylor College Of Medicine |
Method for detection of micrometastatic prostate cancer
|
EP0941368A2
(de)
*
|
1996-11-14 |
1999-09-15 |
Mayo Foundation For Medical Education And Research |
Verfahren für den nachweis von metastatischem prostatakrebs
|
AU722819B2
(en)
*
|
1996-12-06 |
2000-08-10 |
Urocor, Inc. |
Diagnosis of disease state using mRNA profiles
|
AU6551398A
(en)
*
|
1997-03-11 |
1998-09-29 |
Anna C. Ferrari |
Method of detecting prostate cancer metastasis
|
US20070009934A1
(en)
*
|
1997-03-14 |
2007-01-11 |
Kopreski Michael S |
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
|
US8440396B2
(en)
*
|
1997-03-14 |
2013-05-14 |
Oncomedx, Inc. |
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
|
US6190857B1
(en)
*
|
1997-03-24 |
2001-02-20 |
Urocor, Inc. |
Diagnosis of disease state using MRNA profiles in peripheral leukocytes
|
US7332270B1
(en)
|
1997-03-24 |
2008-02-19 |
Urocor, Inc. |
Diagnosis of disease state using mRNA profiles in peripheral leukocytes
|
US7659073B2
(en)
|
1997-04-30 |
2010-02-09 |
Hybritech Incorporated |
Forms of prostate specific antigens and methods for their detection
|
NO972006D0
(no)
*
|
1997-04-30 |
1997-04-30 |
Forskningsparken I Aas As |
Ny metode for diagnose av sykdommer
|
ATE404676T1
(de)
*
|
1997-04-30 |
2008-08-15 |
Hybritech Inc |
Prostat-spezifisches-antigenformen und verfahren zu ihrer bestimmung
|
US7288636B2
(en)
|
1997-04-30 |
2007-10-30 |
Hybritech Incorporated |
Forms of prostate specific antigens and methods for their detection
|
US6235486B1
(en)
|
1997-06-20 |
2001-05-22 |
Mayo Foundation For Medical Education & Research |
Method for detection of breast cancer
|
DE19736691A1
(de)
*
|
1997-08-22 |
1999-02-25 |
Michael Prof Dr Med Giesing |
Verfahren zur Charakterisierung und Identifizierung disseminierter und metastasierter Krebszellen
|
EP1012343A1
(de)
*
|
1997-09-11 |
2000-06-28 |
Abbott Laboratories |
Reagenzien und methoden zur detektion von prostataerkrankungen
|
US6300088B1
(en)
|
1997-11-24 |
2001-10-09 |
Duke University |
Method of detecting prostate specific antigen
|
US5972615A
(en)
*
|
1998-01-21 |
1999-10-26 |
Urocor, Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate disease
|
US6673914B1
(en)
|
1998-01-22 |
2004-01-06 |
John Wayne Cancer Institute |
Human tumor-associated gene
|
CA2330628A1
(en)
*
|
1998-05-01 |
1999-11-11 |
Queen's University At Kingston |
Method for diagnosing a vascular condition
|
JP3677210B2
(ja)
*
|
1998-05-21 |
2005-07-27 |
ダイアデクスアス・インコーポレーテッド |
前立腺がんを診断し、モニターし、そして病期決定する新規な方法
|
US6861215B1
(en)
*
|
1998-05-21 |
2005-03-01 |
Diadexus, Inc. |
Method of diagnosing, monitoring, and staging prostate cancer
|
WO2000005376A1
(en)
*
|
1998-07-24 |
2000-02-03 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Pb 39, a gene dysregulated in prostate cancer, and uses thereof
|
US7226731B1
(en)
|
1998-07-24 |
2007-06-05 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
PB 39, a gene dysregulated in prostate cancer, and uses thereof
|
FR2782730B1
(fr)
*
|
1998-08-25 |
2002-05-17 |
Biocom Sa |
Procede de separation cellulaire pour l'isolation de cellules pathogeniques, notamment cancereuses rares, equipement et reactif pour la mise en oeuvre du procede et application du procede
|
US20060204989A1
(en)
*
|
1998-09-22 |
2006-09-14 |
Kopreski Michael S |
Comparative analysis of extracellular RNA species
|
US8163524B2
(en)
*
|
1998-09-22 |
2012-04-24 |
Oncomedx, Inc. |
Comparative analysis of extracellular RNA species
|
US20080261292A1
(en)
*
|
1998-09-22 |
2008-10-23 |
Oncomedx, Inc. |
Method Enabling the Use of Extracellular Ribonucleic Acid (RNA) Extracted from Plasma or Serum to Detect, Monitor or Evaluate Cancer or Premalignant Conditions
|
US6551778B1
(en)
|
1999-01-28 |
2003-04-22 |
Gen-Probe Incorporated |
Nucleic acid sequences for detecting genetic markers for cancer in a biological sample
|
US6156515A
(en)
|
1999-02-09 |
2000-12-05 |
Urocor, Inc. |
Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
|
US6875854B1
(en)
|
1999-11-18 |
2005-04-05 |
The Brigham And Women's Hospital, Inc. |
Compositions and methods for the improved diagnosis and treatment of germ cell tumors
|
WO2003009806A2
(en)
*
|
2001-07-25 |
2003-02-06 |
Oncomedx Inc. |
Methods for evaluating pathologic conditions using extracellular rna
|
US20100159464A1
(en)
*
|
2001-11-05 |
2010-06-24 |
Oncomedx, Inc. |
Method for Detection of DNA Methyltransferase RNA in Plasma and Serum
|
US20030104454A1
(en)
*
|
2001-11-05 |
2003-06-05 |
Kopreski Michael S. |
Method for detection of DNA methyltransferase RNA in plasma and serum
|
CA2432365A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Jack A. Schalken |
Specific method of prostate cancer detection based on pca3, and kits therefore
|
CN105902559A
(zh)
*
|
2005-08-01 |
2016-08-31 |
俄亥俄州立大学研究基金会 |
用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物
|
CN101296702B
(zh)
*
|
2005-09-12 |
2012-11-28 |
俄亥俄州立大学研究基金会 |
用于诊断或治疗bcl2相关癌症的组合物和方法
|
WO2007044413A2
(en)
*
|
2005-10-05 |
2007-04-19 |
The Ohio State University Research Foundation |
Wwox gene, vectors containing the same, and uses in treatment of cancer
|
CN103993082B
(zh)
|
2006-01-05 |
2017-01-11 |
俄亥俄州立大学研究基金会 |
用于肺癌的诊断、预后和治疗的基于微小rna 的方法和组合物
|
EP2586455B1
(de)
|
2006-01-05 |
2014-06-25 |
The Ohio State University Research Foundation |
Anomalien bei Mikro-RNA-Expressionen in endokrinen und azinösen Pankreastumoren
|
EP2468890B1
(de)
|
2006-01-05 |
2014-03-19 |
The Ohio State University Research Foundation |
Verfahren und Zusammensetzungen auf Mikro-RNA-Basis zur Diagnose und Behandlung von festen Krebsen der Lunge oder Brust
|
EP2369013A1
(de)
|
2006-03-20 |
2011-09-28 |
The Ohio State University Research Foundation |
Mikro-RNA-Fingerabdrücke während humaner Megakaryozytopoiese
|
EP2455492B1
(de)
*
|
2006-07-13 |
2013-11-20 |
The Ohio State University Research Foundation |
Verfahren und Zusammensetzungen auf Mikro-RNA-Basis zur Diagnose und Behandlung von Krankheiten im Zusammenhang mit dem Dickdarm
|
ES2374446T3
(es)
*
|
2006-09-19 |
2012-02-16 |
The Ohio State University Research Foundation |
Expresión de tcl1 en la leucemia linfocítica crónica (llc) regulada por mir-29 y mir-181.
|
WO2008054828A2
(en)
|
2006-11-01 |
2008-05-08 |
The Ohio State University Research Foundation |
Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma
|
EP2109687B1
(de)
*
|
2007-01-31 |
2014-06-04 |
The Ohio State University Research Foundation |
Micro-rna-basierte verfahren zur behandlung von akuter myeloischer leukämie (aml)
|
EP2610347B1
(de)
*
|
2007-04-30 |
2015-04-15 |
The Ohio State University Research Foundation |
Verfahren zur Bestimmung der Prognose eines Subjekts mit Bauchspeicheldrüsenkrebs
|
AU2008262252B2
(en)
*
|
2007-06-08 |
2013-09-12 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Methods for determining hepatocellular carcinoma subtype and detecting hepatic cancer stem cells
|
US8053186B2
(en)
|
2007-06-15 |
2011-11-08 |
The Ohio State University Research Foundation |
Oncogenic ALL-1 fusion proteins for targeting Drosha-mediated microRNA processing
|
JP2010535782A
(ja)
*
|
2007-07-31 |
2010-11-25 |
ズィ、オハイオウ、ステイト、ユーニヴァーサティ、リサーチ、ファウンデイシャン |
Dnmt3a及びdnmt3bを標的にすることによるメチル化を元に戻す方法
|
EP2173908B1
(de)
*
|
2007-08-03 |
2016-01-06 |
The Ohio State University Research Foundation |
Ultrakonservierte bereiche zur kodierung von ncrnas
|
DE102007037008B4
(de)
*
|
2007-08-06 |
2015-09-10 |
Siemens Aktiengesellschaft |
Diagnosesubstanz zur Anwendung in einem Verfahren zur Bestimmung der Aggressivität eines Prostatatumors
|
CA2696887C
(en)
*
|
2007-08-22 |
2016-06-28 |
The Ohio State University Research Foundation |
Methods and compositions for inducing deregulation of epha7 and erk phosphorylation in human acute leukemias
|
JP5401460B2
(ja)
*
|
2007-09-06 |
2014-01-29 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
ヒト卵巣癌中のマイクロrnaシグネチャー
|
US20090136942A1
(en)
*
|
2007-09-18 |
2009-05-28 |
Oncomedx, Inc. |
Analysis of Extracellular RNA
|
US20100285471A1
(en)
*
|
2007-10-11 |
2010-11-11 |
The Ohio State University Research Foundation |
Methods and Compositions for the Diagnosis and Treatment of Esphageal Adenocarcinomas
|
AU2008316577B2
(en)
|
2007-10-26 |
2014-04-10 |
The Ohio State University Research Foundation |
Methods for identifying fragile histidine triad (FHIT) interaction and uses thereof
|
JP2011505143A
(ja)
*
|
2007-11-30 |
2011-02-24 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
マイクロrna発現プロファイリング及び肺癌における末梢血ターゲティング
|
US20110054009A1
(en)
*
|
2008-02-28 |
2011-03-03 |
The Ohio State University Research Foundation |
MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders
|
US20110052502A1
(en)
*
|
2008-02-28 |
2011-03-03 |
The Ohio State University Research Foundation |
MicroRNA Signatures Associated with Human Chronic Lymphocytic Leukemia (CCL) and Uses Thereof
|
JP5745401B2
(ja)
|
2008-06-11 |
2015-07-08 |
アメリカ合衆国 |
肝細胞癌についての予測マーカーとしてのMiR−26ファミリーの使用および療法に対する反応性
|
AU2010321555B2
(en)
|
2009-11-23 |
2015-10-15 |
The Ohio State University |
Materials and methods useful for affecting tumor cell growth, migration and invasion
|
ES2606146T3
(es)
|
2010-11-12 |
2017-03-22 |
The Ohio State University Research Foundation |
Métodos relacionados con microARN-21 y reparación de desapareamiento en cáncer colorrectal
|
CN103313706A
(zh)
|
2010-11-15 |
2013-09-18 |
俄亥俄州立大学研究基金会 |
控制释放粘膜粘合系统
|
EP2683387A4
(de)
|
2011-03-07 |
2014-09-03 |
Univ Ohio State |
Durch mikro-rna-155 (mir-155) induzierte mutatorgenaktivität gegen entzündungen und krebs
|
WO2013056217A1
(en)
|
2011-10-14 |
2013-04-18 |
The Ohio State University |
Methods and materials related to ovarian cancer
|
JP2015501843A
(ja)
|
2011-12-13 |
2015-01-19 |
オハイオ・ステイト・イノベーション・ファウンデーション |
miR−21およびmiR−29a、エキソソーム阻害、およびがん転移に関する方法および組成物
|
JP2015511121A
(ja)
|
2012-01-20 |
2015-04-16 |
ジ・オハイオ・ステート・ユニバーシティ |
浸潤性および予後に関する乳がんバイオマーカーシグネチャー
|
CN111518170A
(zh)
*
|
2020-05-09 |
2020-08-11 |
新乡医学院 |
基于fret的psa荧光探针、制备方法及其应用
|